What is the Current Share Price of Gujarat Terce Laboratories Ltd?
- Answer Field
-
Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.80 as on Apr 23 2026 03:29 PM.
As of the latest trading session, GUJARAT TERCE LABORATORIES LTD share price is currently at ₹37.8, which is down by ₹-1.09 from its previous closing. Today, the stock has fluctuated between ₹37.22 and ₹41.35. Over the past year, GUJARAT TERCE LABORATORIES LTD has achieved a return of -36.75%. In the last month alone, the return has been 1.01%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 12.29 |
| Operating Expense | 11.29 |
| Net Profit | 0.76 |
| Net Profit Margin (%) | 6.18 |
| Earnings Per Share (EPS) | 0.95 |
| EBITDA | 1.27 |
| Effective Tax Rate (%) | 32.74 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 33.21 | 14.38 | 1.72 | 254.50 | 23.12 | 41.45 |
| BLISS GVS PHARMA LTD. | 273.75 | 26.17 | 2.55 | 2895.97 | 105.05 | 277.05 |
| CIPLA LTD | 1235.00 | 20.98 | 3.03 | 99761.15 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 315.25 | 10.49 | 2.37 | 927.81 | 252.15 | 399.00 |
| GLAXOSMITHKLINE PHARMA LT | 2462.75 | 41.48 | 24.43 | 41720.47 | 2218.00 | 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 33.21 | 31.93 | 4.62 | 254.50 | 23.12 | 41.45 |
| AMRUTAJAN HEALTH LTD | 571.50 | 28.58 | 4.83 | 1652.24 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8443.20 | 101.47 | 26.41 | 21108.00 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD. | 273.75 | 37.30 | 2.62 | 2895.97 | 105.05 | 277.05 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Gujarat Terce Laboratories Limited, incorporated in 1985, is a trusted manufacturer of high quality medication at affordable rates for the common man. Company specialise in producing oral solid dosages, including tablets and capsules, that address various therapeutic needs.
Headquartered in Ahmedabad, Gujarat, Terce offers an extensive portfolio featuring over 125 products and more than 64 well-established brands.
By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing. In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange. In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat. As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.
The Company offers products in the form of tablets, capsules, syrups, and injections. The installed capacity of the Company is 270 million tablets and 108 million capsules per annum. It focuses on formulation improvements, new product development, and research to identify gaps in existing treatment options.
The Company otherwise or hence maintains strict and controlled environment for manufacturing and adheres to Good Manufacturing Practices and Good Laboratory Practices to assure highest level of patient safety and outcome efficacy. It has well-defined Total Quality Management System in place to continuously optimize products and processes. Each process is thoroughly monitored and data is collected for analysis which helps in planning corrective and preventive strategies for quality control.
To serve the needs of patients and healthcare professionals, Company focus on early and rapid detection of diseases. Their team of scientists is supported by doctors, patients and marketing team in identifying pressing needs and developing solutions. It has capabilities of innovation across generic drugs to complex formulations, biosimilars and new molecular entity.
Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.80 as on Apr 23 2026 03:29 PM.
The market cap of Gujarat Terce Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 29.50 as on Apr 23 2026 03:29 PM.
The 52 Week High and Low of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 68.40 and ₹ 29.00.
The 1 year returns on the stock has been -36.75%.
As on Apr 23 2026 03:29 PM the price-to-earnings (PE) ratio for Gujarat Terce Laboratories Ltd share is -23.86.
As on Apr 23 2026 03:29 PM, the price-to-book (PB) ratio for Gujarat Terce Laboratories Ltd share is 11.40.
You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Gujarat Terce Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Gujarat Terce Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found